Online Business

Fortis Healthcare net rises 23% at Rs 13 cr

Driven by robust growth in its larger units, hospital chain Fortis Healthcare today reported a 23.4 per cent increase in net profit at Rs 12.9 crore for the second quarter ended on September 30, 2009. Sensex ends up 35pts "During the quarter, our larger hospitals located in Delhi, Noida, Jaipur and Bangalore have reported robust growth which has pushed the net profit," Fortis Healthcare President Strategy and Organisation Daljit Singh told PTI. During the quarter, in terms of the total income it has reported an increase of 20.9 per cent at Rs 190.49 crore as compared to Rs 157.54 crore in the corresponding quarter last fiscal. In the second quarter, it has executed an agreement for acquisition of 10 hospitals (including two under construction) from Wockhardt Hospitals Ltd for Rs 909 Cr, which will add 1,902 beds to its capacity and enlarge its footprint in southern, western and eastern regions of India. Singh, however, declined to comment on queries related to contribution from Wockhardt hospitals in its total income. The company expects the acquistion to be completed by December 2009.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Bharti said to offer 320 bps more than Libor for MTN loans
Bharti Airtel may pay lenders as much as 3.2 percentage points more than the London interbank offered rate (Libor) as it seeks to borrow $5 billion to buy a stake in MTN Group, three people familiar with the matter said.
Popular Articles

Markets at a glance
Worries of rising food prices and a hike in interest rates weighed on the market sentiment. During the week, the BSE Sensex fell 400 points or 2.3 per cent to 16,720, while Nifty fell 130 points or 2.5 per cent to 4,988. However, mid-cap and small-cap stocks performed better, BSE Mid-Cap index fell by 1.6 per cent and Small-cap index declined by 1.04 per cent during the week.

Cipla gets NPPA notice on overpricing drugs
The National Pharmaceutical Pricing Authority (NPPA) has sent a notice to Cipla for allegedly overcharging customers. The government arm has imposed a fine on the company for selling Ciprofloxacin and Doxycycline medicines at a higher price than the one stated by the government.